Cargando…

Comparison urine neutrophil gelatinase - associated lipocalin with standard parameters in monitoring activity Lupus nephritis: Class IV

BACKGROUND: Lupus nephritis (LN) is one of the most serious complications in the development of systemic lupus erythematosus, that can adversely affect the course and prognosis of this autoimmune disease. Therefore, monitoring the effect of applied therapy, achieving remission, or monitoring class I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rabrenović, Violeta, Petrović, Milica, Rabrenović, Milorad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Medical Biochemists of Serbia, Belgrade 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920933/ https://www.ncbi.nlm.nih.gov/pubmed/36819131 http://dx.doi.org/10.5937/jomb0-35933

Ejemplares similares

Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis
por: Satirapoj, Bancha, et al.
Publicado: (2017)

Urinary Neutrophil Gelatinase-Associated Lipocalin to Monitor Lupus Nephritis Disease Activity
por: Susianti, Hani, et al.
Publicado: (2015)

Urinary Neutrophil Gelatinase-Associated Lipocalin and Urinary Soluble CXCL16 as Biomarkers of Activity in Pediatric Lupus Nephritis
por: El-Gamasy, M. A., et al.
Publicado: (2018)

Value of Urinary Neutrophil Gelatinase-Associated Lipocalin versus Conventional Biomarkers in Predicting Response to Treatment of Active Lupus Nephritis
por: El-Mohsen, Mohamed Abd, et al.
Publicado: (2020)

Elevated Urinary Neutrophil Gelatinase-Associated Lipocalin Is a Biomarker for Lupus Nephritis: A Systematic Review and Meta-Analysis
por: Gao, Yueming, et al.
Publicado: (2020)

Polyomavirus BK, BKV microRNA, and urinary neutrophil gelatinase-associated lipocalin can be used as potential biomarkers of lupus nephritis
por: Li, Yi-Jung, et al.
Publicado: (2019)

Plasma and urine neutrophil gelatinase-associated lipocalin in septic and nonseptic ICU patients
por: Vrettou, CS, et al.
Publicado: (2012)

Effects of Therapy on Urine Neutrophil Gelatinase-Associated Lipocalin in Nondiabetic Glomerular Diseases with Proteinuria
por: Sirisopha, Amnuay, et al.
Publicado: (2016)

Urine neutrophil gelatinase‐associated lipocalin to diagnose and characterize acute kidney injury in dogs
por: Monari, Erika, et al.
Publicado: (2019)

Economic impact and cost-effectiveness of urine neutrophil gelatinase-associated lipocalin following cardiac surgery
por: Shaw, A, et al.
Publicado: (2010)

Urine neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute canine kidney injury
por: Lee, Ya-Jane, et al.
Publicado: (2012)

The different molecular forms of urine neutrophil gelatinase-associated lipocalin present in dogs with urinary diseases
por: Hsu, Wei-Li, et al.
Publicado: (2014)

Impact of Near Real-Time Urine Neutrophil Gelatinase–Associated Lipocalin Assessment on Clinical Practice
por: Varnell, Charles D., et al.
Publicado: (2017)

Association of peripheral blood neutrophil gelatinase‐associated lipocalin levels with bone marrow neutrophil gelatinase‐associated lipocalin levels and neutrophil count in hematologic malignancy
por: Cho, Chi‐Hyun, et al.
Publicado: (2019)

Neutrophil Gelatinase-Associated Lipocalin Levels During Pneumoperitoneum
por: Kiseli, Mine, et al.
Publicado: (2017)

Neutrophil gelatinase–associated lipocalin as an immunomodulator in endocrine hypertension
por: Araos, Patricio, et al.
Publicado: (2022)

Plasma and urine neutrophil gelatinase-associated lipocalin as markers of acute kidney injury in critically ill adults
por: Matsa, R, et al.
Publicado: (2012)

Urine and serum neutrophil gelatinase-associated lipocalin cut-off point for the prediction of acute kidney injury
por: Merrikhi, Alireza, et al.
Publicado: (2014)

Correction: Urine neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute canine kidney injury
por: Lee, Ya-Jane, et al.
Publicado: (2013)

Comparison of urine neutrophil gelatinase-associated lipocalin and interleukin-18 in prediction of acute kidney injury in adults
por: Gan, Jiadi, et al.
Publicado: (2018)

Identification of urine neutrophil gelatinase-associated lipocalin molecular forms and their association with different urinary diseases in cats
por: Wu, Po-Han, et al.
Publicado: (2019)

Sterile leukocyturia affects urine neutrophil gelatinase-associated lipocalin concentration in type 2 diabetic patients
por: Gala-Błądzińska, Agnieszka, et al.
Publicado: (2016)

Urine neutrophil gelatinase-associated lipocalin concentration in healthy newborns during the first three postnatal days
por: Mikulić, Vinka, et al.
Publicado: (2020)

Urine Neutrophil Gelatinase-associated Lipocalin (NGAL) for Prediction of Persistent AKI and Major Adverse Kidney Events
por: Lumlertgul, Nuttha, et al.
Publicado: (2020)

Urine Neutrophil Gelatinase-Associated Lipocalin a Possible Diagnostic Marker for Egyptian Hepatocellular Carcinoma Patients
por: Abdelsameea, Eman, et al.
Publicado: (2020)

Relationship between neutrophil gelatinase-associated lipocalin levels and disease parameters including clinicopathological parameters and various cytokine levels in systemic lupus erythematosus
por: CHOI, Eun Wha
Publicado: (2023)

Neutrophil gelatinase-associated lipocalin in ICU patients developing oliguria
por: Roman, A, et al.
Publicado: (2011)

Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer
por: Candido, Saverio, et al.
Publicado: (2014)

Urinary Excretion of Neutrophil Gelatinase-Associated Lipocalin in Diabetic Rats
por: Arellano-Buendía, Abraham Said, et al.
Publicado: (2014)

The origin of plasma neutrophil gelatinase-associated lipocalin in cardiac surgery
por: Passov, Arie, et al.
Publicado: (2019)

Role of neutrophil gelatinase-associated lipocalin in renal cell carcinoma
por: Che, Kai, et al.
Publicado: (2021)

Plasma neutrophil gelatinase-associated lipocalin and kidney graft outcome
por: Kremer, Daan, et al.
Publicado: (2021)

The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL)
por: Romejko, Katarzyna, et al.
Publicado: (2023)

Comparison of Serum and Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL) With Serum Creatinine in Prediction of Kidney Suitability for Transplantation
por: Mahdavi-Mazdeh, Mitra, et al.
Publicado: (2012)

Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease
por: Liu, Kathleen D, et al.
Publicado: (2013)

Plasma and Urine Neutrophil Gelatinase–Associated Lipocalin (NGAL) in Dogs with Acute Kidney Injury or Chronic Kidney Disease
por: Steinbach, S., et al.
Publicado: (2014)

Effectiveness of Plasma and Urine Neutrophil Gelatinase-Associated Lipocalin for Predicting Acute Kidney Injury in High-Risk Patients
por: Yi, Ahram, et al.
Publicado: (2021)

Evaluation of Serum and Urine Neutrophil Gelatinase-associated Lipocalin and Cystatin C as Biomarkers of Acute Kidney Injury in Horses
por: Siwińska, Natalia, et al.
Publicado: (2021)

Analysis of bone marrow supernatant neutrophil gelatinase‐associated lipocalin and hematological parameters in hematological malignancy
por: Cho, Chi‐Hyun, et al.
Publicado: (2020)

Association of Urinary Lipocalin-2 with Lupus Nephritis
por: Sharifipour, Farzaneh, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qt3gtdfo6sqfe9qi9iqacofdgm